We will start the new year in print with a selection of the latest research from the European Journal of Human Genetics. Middleton et al. get the ball rolling with a fresh look at the role of the Genetic counsellor in the United Kingdom [1] and a policy paper on the scope of the Genetic Counsellor and Consultant Clinical Geneticist roles [2]. Rumping et al. provide a new look at potential pathogenic mechanisms in Fraser syndrome [3].
Neurodevelopmental conditions are recognised as being challenging to obtain a molecular diagnosis for, given the genetic heterogeneity and varied clinical phenotypes [4, 5]. Van der Sanden et al. provide evidence that genome sequencing is a valuable first tier test; one reason being that it can identify copy number variants likely to be missed by exome sequencing [6, 7]. An additional benefit of genome sequencing (over exome sequencing) is that it can detect repeat expansions. Rafehi et al. identified an expansion causing myotonic dystrophy type 2 in an autism family, being associated with a mild myotonic dystrophy phenotype but not segregating with autism [8]. Genome sequencing also remains a powerful research tool. Boehm et al. utilise genome sequencing to identify a missense variant in PAX6 associated with diabetes [9]. Less sophisticated sequencing techniques still have a role to play. Mezad-Koursh et al. used routine clinical testing to identify mosaic biallelic variants in BCOR in an unusual eye phenotype [10]. Koopmann et al. utilised exome sequencing to identify LDB3 variants as a novel cause of cardiomyopathy [11]. A routinely available SNP-array was used by Fabian et al. to identify copy number variants associated with anorectal malformations [12]. They used this design to implicate novel genes in anorectal malformations including EXOC6B. Genomic testing can also be used to track founder mutational events within populations, in this case Canavan disease [13, 14]. Precise molecular diagnosis for neurodevelopmental conditions also facilitate phenotyping studies; such as this report of a novel case series of individuals with PURA variants [15]. This is important for clinical management.
The technical aspects of genetic testing may be challenging, but the counselling and family communication issues can be even more so. Young et al. review interventions to increase information sharing in families with genetic forms of cancer [16]. The review suggests that tailored genetic counselling with information follow up can increase information sharing on genetic risk within cancer families (BRCA, Lynch). Related to this issue of information sharing is the views of the general public on genomic testing. Sherburn et al. provide a scoping review on this; highlighting the diversity of views and opinions that could influence uptake of testing [17]. Using genomic technologies to expand genomic screening in the general population is controversial. Van den Heuvel et al. report a scoping review of societal implications of expanded carrier screening [18]. They identify concerns around medicalisation of carrier status, stigmatisation of carriers and equity of access [18, 19].
References
Middleton A, Taverner N, Moreton N, Rizzo R, Houghton C, Watt C, et al. The genetic counsellor role in the United Kingdom: position on behalf of the Association of Genetic Nurses and Counsellors (AGNC), Endorsed by the Genetic Counsellor Registration Board (GCRB) and Academy for Healthcare Science (AHCS). Eur J Hum Genet. 2022. https://doi.org/10.1038/s41431-022-01212-9.
Middleton A, Taverner N, Houghton C, Smithson S, Balasubramanian M, Elmslie F. Scope of professional roles for genetic counsellors and clinical geneticists in the United Kingdom: position on behalf of the Association of Genetic Nurses and Counsellors and the Clinical Genetics Society. Eur J Hum Genet. 2022. https://doi.org/10.1038/s41431-022-01214-7.
Rumping L, Hennekam RCM, Alders M, van Haelst MM. “Hypothesis: patient with possible disturbance in programmed cell death”: further insights in pathogenicity and clinical features of Fraser syndrome. Eur J Hum Genet. 2022. https://doi.org/10.1038/s41431-022-01175-x.
McNeill A, Iovino E, Mansard L, Vache C, Baux D, Bedoukian E, et al. SLC12A2 variants cause a neurodevelopmental disorder or cochleovestibular defect. Brain. 2020;143:2380–7. https://doi.org/10.1093/brain/awaa176.
McNeill A, Aurora P, Rajput K, Nash R, Stals K, Robinson H, et al. Dominant and recessive SLC12A2-syndrome. Am J Med Genet A. 2022;188:996–9. https://doi.org/10.1002/ajmg.a.62573.
van der Sanden BPGH, Schobers G, Corominas Galbany J, Koolen DA, Sinnema M, van Reeuwijk J, et al. The performance of genome sequencing as a first-tier test for neurodevelopmental disorders. Eur J Hum Genet. 2022. https://doi.org/10.1038/s41431-022-01185-9.
Li D. Genome sequencing as a single comprehensive test in molecular diagnosis. Eur J Hum Genet. 2022. https://doi.org/10.1038/s41431-022-01215-6.
Rafehi H, Green C, Bozaoglu K, Gillies G, Delatycki MB, Lockhart PJ, et al. Unexpected diagnosis of myotonic dystrophy type 2 repeat expansion by genome sequencing. Eur J Hum Genet. 2022. https://doi.org/10.1038/s41431-022-01166-y.
Boehm BO, Kratzer W, Bansal V. Whole-genome sequencing of multiple related individuals with type 2 diabetes reveals an atypical likely pathogenic mutation in the PAX6 gene. Eur J Hum Genet. 2022. https://doi.org/10.1038/s41431-022-01182-y.
Mezad-Koursh D, Rosenfeld E, Bachar Zipori A, Zur D, Elhanan E, Ben-Shachar S. A rare genotype of biallelic mosaic variants in BCOR gene causing a bilateral ocular anterior segment dysgenesis and cataracts. Eur J Hum Genet. 2022. https://doi.org/10.1038/s41431-022-01195-7.
Koopmann TT, Jamshidi Y, Naghibi-Sistani M, van der Klift HM, Birjandi H, Al-Hassnan Z, et al. Biallelic loss of LDB3 leads to a lethal pediatric dilated cardiomyopathy. Eur J Hum Genet. 2022. https://doi.org/10.1038/s41431-022-01204-9.
Fabian J, Dworschak GC, Waffenschmidt L, Schierbaum L, Bendixen C, Heilmann-Heimbach S, et al. Genome-wide identification of disease-causing copy number variations in 450 individuals with anorectal malformations. Eur J Hum Genet. 2022. https://doi.org/10.1038/s41431-022-01216-5.
Kotambail A, Selvam P, Muthusamy K, Thomas M, Sudhakar SV, Ghati C, et al. Clustering of Juvenile Canavan disease in an Indian community due to population bottleneck and isolation: genomic signatures of a founder event. Eur J Hum Genet. 2022. https://doi.org/10.1038/s41431-022-01198-4.
Das R. On clustering of Juvenile Canavan disease in an Indian community due to population bottleneck and isolation: genomic signatures of a founder event. Eur J Hum Genet. 2022. https://doi.org/10.1038/s41431-022-01221-8.
Dai W, Sun Y, Fan Y, Gao Y, Zhan Y, Wang L, et al. A 25 Mainland Chinese cohort of patients with PURA-related neurodevelopmental disorders: clinical delineation and genotype-phenotype correlations. Eur J Hum Genet. 2022. https://doi.org/10.1038/s41431-022-01217-4.
Young AL, Imran A, Spoelma MJ, Williams R, Tucker KM, Halliday J, et al. Proband-mediated interventions to increase disclosure of genetic risk in families with a BRCA or Lynch syndrome condition: a systematic review. Eur J Hum Genet. 2022. https://doi.org/10.1038/s41431-022-01200-z.
Sherburn IA, Finlay K, Best S. How does the genomic naive public perceive whole genomic testing for health purposes? A scoping review. Eur J Hum Genet. 2022. https://doi.org/10.1038/s41431-022-01208-5.
van den Heuvel LM, van den Berg N, Janssens ACJW, Birnie E, Henneman L, Dondorp WJ, et al. Societal implications of expanded universal carrier screening: a scoping review. Eur J Hum Genet. 2022. https://doi.org/10.1038/s41431-022-01178-8.
Dive L, Freeman L, McEwen A. Genetic counsellors play a key role in supporting ethically responsible expanded universal carrier screening. Eur J Hum Genet. 2022. https://doi.org/10.1038/s41431-022-01218-3.
Funding
No specific funding.
Author information
Authors and Affiliations
Contributions
AM conceived and wrote this editorial.
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
McNeill, A. New year, new genes. Eur J Hum Genet 31, 1–2 (2023). https://doi.org/10.1038/s41431-022-01271-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41431-022-01271-y